Umoja, founded in 2019, is developing in-body treatments to boost the effectiveness of immune cell therapies, targeting both ...
North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...
After hours: January 22 at 6:50:24 PM EST Loading Chart for ACRS ...
After hours: January 23 at 5:01:15 PM EST Loading Chart for CLDX ...
Sanofi S.A. Part Cert 0.06% €8.19M ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.